Skip to search formSkip to main contentSkip to account menu

CRIPAK gene

Known as: FLJ34443, CYSTEINE-RICH INHIBITOR OF PAK1, cysteine rich PAK1 inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Radiogenomic Analysis of Breast Cancer by Using B-Mode and Vascular US and RNA Sequencing.
Background Radiogenomic investigations for breast cancer provide an understanding of tumor heterogeneity and discover image… 
Review
2020
Review
2020
[Identification of a critical region on chromosome 4p16.3 for Wolf-Hirschhorn syndrome-associated fetal growth retardation].
OBJECTIVE To analyze ultrasonographic finding in fetuses with Wolf-Hirschhorn syndrome (WHS) and refine the critical region on… 
2019
2019
Abstract 3413: CRIPAK genomic alterations are associated with indolent lung adenocarcinoma and predicts longer survival
2016
2016
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Harbors Frequent Splicesosome Mutations That Cause Aberrant RNA Splicing Affecting Genes Critical in pDC Differentiation and Function
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive malignancy thought to result from transformation of… 
2015
2015
Abstract PD3-6: ConvertHER: Evolution of genomic alterations from primary to metastatic breast cancer
Background: Changes in breast cancer receptor status over disease progression and treatment have been described to a point that… 
2014
2014
Abstract 558: Mutational heterogeneity related to neoadjuvant therapy response in muscle invasive urothelial cell carcinoma revealed by whole-exome sequencing
Twenty five to thirty-five percent of urothelial cell carcinoma (UCC) patients either present with or develop muscle-invasive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)